MedPath

VASOVIST

VASOVIST

Discontinued
DIN Number

02286319

Drug Class

Human

Market Date

Aug 20, 2007

Company
HC

Bayer Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02286319
AIG Number0151671001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V08CA11 GADOFOSVESET
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification36:89.00*
Health Canada Classification

ACTIVE INGREDIENTS (1)

GADOFOSVESET TRISODIUMActive
Strength: 244 MG / ML
Monograph: GADOFOSVESET TRISODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.